Andrew Crombie

Andrew Crombie

Auto-generated profile, based on publicly available information

Andrew Crombie

Microbial Screening Technologies Pty. Ltd, Smithfield, NSW 2164, Australia

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 April 2018 in Organic & Biomolecular Chemistry
Verified
Journal Article
Closed access
PDF file
MMMahmud T. Morshed
Mahmud T. Morshed
DVDaniel Vuong
Daniel Vuong
ACAndrew Crombie
Andrew Crombie
ALAlastair E. Lacey
Alastair E. Lacey
Peter KarusoPeter Karuso
Peter Karuso
Andrew PiggottAndrew Piggott
Andrew Piggott
Reinvestigating antibiotic scaffolds that were identified during the Golden Age of antibiotic discovery, but have long since been “forgotten”, has proven to be an effective strategy for delivering next-generation antibiotics capable of combatting multidrug-resistant superbugs. In this study, we have revisited the trichloro-substituted depsidone, nidulin, as a selective and unexploited antibiotic lead produced by the fungus Aspergillus unguis. Manipulation of halide ion concentration proved to be a powerful tool for modulating secondary metabolite production and triggering quiescent pathways in A. unguis. Supplementation of the culture media with chloride resulted in a shift in co-metabolite profile to dichlorounguinols and nornidulin at the expense of the non-chlorinated parent, unguinol. Surprisingly, only marginal enhancement of nidulin was observed, suggesting O-methylation may be rate-limiting. Similarly, supplementation of the media with bromide led to the production of the corresponding bromo-analogues, but also resulted in a novel family of depsides, the unguidepsides. Unexpectedly, depletion of chloride from the media halted the biosynthesis of the non-chlorinated parent compound, unguinol, and redirected biosynthesis to a novel family of ring-opened analogues, the unguinolic acids. Supplementation of the media with a range of unnatural salicylic acids failed to yield the corresponding nidulin analogues, suggesting the compounds may be biosynthesised by a single polyketide synthase. In total, 12 new and 11 previously reported nidulin analogues were isolated, characterised and assayed for in vitro activity against a panel of bacteria, fungi and mammalian cells, providing a comprehensive structure–activity profile for the nidulin scaffold.

29 January 2024 in Chemical Science
Verified
Journal Article
Open access
PDF file
AAAmr Arishi
Amr Arishi
ZSZhuo Shang
Zhuo Shang
ELErnest Lacey
Ernest Lacey
ACAndrew Crombie
Andrew Crombie
DVDaniel Vuong
Daniel Vuong
YCYit-Heng Chooi
Yit-Heng Chooi
Luteodienoside A – a glycosylated polyketide produced by the Australian fungus Aspergillus luteorubrus is biosynthesised by a polyketide synthase with a carnitine O-acyltransferase domain capable of adding glucinol to the polyketide product.

8 January 2021 in Organic & Biomolecular Chemistry
Verified
Journal Article
Closed access
PDF file
MMMahmud T. Morshed
Mahmud T. Morshed
HNHang Thi Nguyen
Hang Thi Nguyen
DVDaniel Vuong
Daniel Vuong
ACAndrew Crombie
Andrew Crombie
ELErnest Lacey
Ernest Lacey
Andrew PiggottAndrew Piggott
Andrew Piggott
In this study, we report the semisynthesis and in vitro biological evaluation of thirty-four derivatives of the fungal depsidone antibiotic, unguinol. Initially, the semisynthetic modifications were focused on the two free hydroxy groups (3-OH and 8-OH), the three free aromatic positions (C-2, C-4 and C-7), the butenyl side chain and the depsidone ester linkage. Fifteen first-generation unguinol analogues were synthesised and screened against a panel of bacteria, fungi and mammalian cells to formulate a basic structure activity relationship (SAR) for the unguinol pharmacophore. Based on the SAR studies, we synthesised a further nineteen second-generation analogues, specifically aimed at improving the antibacterial potency of the pharmacophore. In vitro antibacterial activity testing of these compounds revealed that 3-O-(2-fluorobenzyl)unguinol and 3-O-(2,4-difluorobenzyl)unguinol showed potent activity against both methicillin-susceptible and methicillin-resistant Staphylococcus aureus (MIC 0.25–1 μg mL−1) and are promising candidates for further development in vivo.

24 October 2024 in Chemical Science
Verified
Journal Article
Open access
PDF file
NSNicolau Sbaraini
Nicolau Sbaraini
ACAndrew Crombie
Andrew Crombie
JKJohn A. Kalaitzis
John A. Kalaitzis
DVDaniel Vuong
Daniel Vuong
JBJoe Bracegirdle
Joe Bracegirdle
YCYit-Heng Chooi
Yit-Heng Chooi
The aqu BGC from Austroacremonium gemini encodes a versatile polyketide synthase capable of synthesising heteromeric depsides with diverse alkyl side chains.